Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Gill S"'
Autor:
Wildgoose P; Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Servidio-Italiano F; Colorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada., Raphael MJ; Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Slovinec D'Angelo M; Colorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada., Macaulay C; Colorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada., Kassam S; Southlake Stronach Regional Cancer Centre, Newmarket, ON L3Y 2P9, Canada., Nixon N; Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada., Perea J; Department of Medicine, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain., Hamilton S; BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Ramjeesingh R; Nova Scotia Cancer Centre, Dalhousie University, Halifax, NS B3H 1V8, Canada., Gill S; BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Pollett A; Division of Diagnostic Medical Genetics, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada., Ogino S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Ugai T; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Gupta A; Adolescent & Young Adult (AYA) Oncology Program, Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jul 19; Vol. 31 (7), pp. 4063-4078. Date of Electronic Publication: 2024 Jul 19.
Autor:
Oveisi N; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada., Cheng V; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada., Taylor D; Patient Research Partner., Bechthold H; Patient Research Partner., Barnes M; Patient Research Partner.; Registered Physiotherapist, Pelvic Health Provider, Vancouver, BC, Canada., Jansen N; Patient Research Partner., McTaggart-Cowan H; BC Cancer, Vancouver, BC V5Z 1M9, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada., Brotto LA; Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Peacock S; BC Cancer, Vancouver, BC V5Z 1M9, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada., Hanley GE; Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Gill S; BC Cancer, Vancouver, BC V5Z 1M9, Canada.; Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Rayar M; Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Srikanthan A; Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, Ottawa, ON K1H 8M5, Canada.; The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada., De Vera MA; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada.; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC V6Z 1Y6, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 22; Vol. 31 (4), pp. 1689-1700. Date of Electronic Publication: 2024 Mar 22.
Autor:
Hardaker EL; Oncology R&D, AstraZeneca, Cambridge, UK., Sanseviero E; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Karmokar A; Oncology R&D, AstraZeneca, Cambridge, UK., Taylor D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Milo M; Oncology R&D, AstraZeneca, Cambridge, UK., Michaloglou C; Oncology R&D, AstraZeneca, Cambridge, UK., Hughes A; Oncology R&D, AstraZeneca, Cambridge, UK., Mai M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., King M; Oncology R&D, AstraZeneca, Cambridge, UK., Solanki A; Oncology R&D, AstraZeneca, Cambridge, UK., Magiera L; Oncology R&D, AstraZeneca, Cambridge, UK., Miragaia R; Oncology R&D, AstraZeneca, Cambridge, UK., Kar G; Oncology R&D, AstraZeneca, Cambridge, UK., Standifer N; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Tempest Therapeutics, Brisbane, CA, USA., Surace M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Gill S; Oncology R&D, AstraZeneca, Cambridge, UK., Peter A; Oncology R&D, AstraZeneca, Cambridge, UK., Talbot S; Oncology R&D, AstraZeneca, Cambridge, UK., Tohumeken S; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Fryer H; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mostafa A; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mulgrew K; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Lam C; Oncology R&D, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Sutton D; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Carnevalli L; Oncology R&D, AstraZeneca, Cambridge, UK., Calero-Nieto FJ; Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Oncology R&D, AstraZeneca, Cambridge, UK., Pierce AJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Crescendo Biologics Limited, Cambridge, UK., Wilson Z; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Nyoni L; Oncology R&D, AstraZeneca, Cambridge, UK., Martins CP; Oncology R&D, AstraZeneca, Cambridge, UK., Baker T; CPSS AST, AstraZeneca, Cambridge, UK., Serrano de Almeida G; CPSS AST, AstraZeneca, Cambridge, UK., Ramlaoui Z; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Bidar A; CPSS, Imaging, AstraZeneca, Gothenburg, Sweden., Phillips B; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Boland J; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Iyer S; Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Loembé AB; Early Clinical Development, AstraZeneca, Oss, the Netherlands., Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA., Duvvuri U; UPMC Department of Otolaryngology and UPMC Hillman Cancer Center, 200 Lothrop St. Suite 500, Pittsburg, PA, 15213, USA., Lou PJ; National Taiwan University Hospital, No. 7, Chung Shan S. Rd. (Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 10002, Taiwan., Nance MA; VA Pittsburgh Healthcare System, University Drive C, Pittsburg, PA, 15240, USA., Gomez Roca CA; Institut Claudius Regaud-Cancer Comprehensive Center, 1 Avenue Irene Joliot-Curie, IUCT-O, Toulouse, 31059 Cedex 9, France., Cadogan E; Oncology R&D, AstraZeneca, Cambridge, UK., Critichlow SE; Oncology R&D, AstraZeneca, Cambridge, UK., Fawell S; Oncology R&D, AstraZeneca, Boston, MA, USA., Cobbold M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Dean E; Oncology R&D, AstraZeneca, Cambridge, UK., Valge-Archer V; Oncology R&D, AstraZeneca, Cambridge, UK., Lau A; Oncology R&D, AstraZeneca, Cambridge, UK., Gabrilovich DI; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. dmitry.gabrilovich@astrazeneca.com., Barry ST; Oncology R&D, AstraZeneca, Cambridge, UK. simon.t.barry@astrazeneca.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 24; Vol. 15 (1), pp. 1700. Date of Electronic Publication: 2024 Feb 24.
Autor:
Oveisi N; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada., Cheng V; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada., Brotto LA; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Peacock S; BC Cancer, Vancouver, BC, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada., McTaggart-Cowan H; BC Cancer, Vancouver, BC, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada., Hanley G; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Gill S; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Rayar M; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Srikanthan A; Faculty of Medicine University of Ottawa, Ottawa, ON, Canada.; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Ellis U; University of British Columbia Library, Vancouver, BC, Canada., De Vera MA; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada.; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2023 Oct 31; Vol. 7 (6).
Autor:
Haddad AF; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Young JS; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Gill S; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Aghi MK; Department of Neurological Surgery, University of California, San Francisco, CA, USA. Electronic address: manish.aghi@ucsf.edu.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2022 Nov; Vol. 86 (Pt 3), pp. 532-541. Date of Electronic Publication: 2022 Mar 09.
Autor:
Stecca CE; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Alt M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Michelis G; Department of Psychiatry Instituto de Psiquiatria, Florianopolis, SC, Brazil., Fallah-Rad N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Gill S; BC Cancer Agency, Vancouver, BC, Canada., Elliot M; Division of Psychiatry, Princess Margaret Cancer Centre, Toronto, ON, Canada., Sridhar SS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address: srikala.sridhar@uhn.ca.
Publikováno v:
Seminars in oncology [Semin Oncol] 2022 Oct; Vol. 49 (5), pp. 383-388. Date of Electronic Publication: 2022 Sep 08.
Autor:
Gill S; Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia., Nowak AK; Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia.; Institute for Respiratory Health, Nedlands, Western Australia, Australia., Bowyer S; Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia., Endersby R; University of Western Australia, Crawley, Western Australia, Australia.; Telethon Kids Institute, Nedlands, Western Australia, Australia., Ebert MA; Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia., Cook A; University of Western Australia, Crawley, Western Australia, Australia.; Institute for Respiratory Health, Nedlands, Western Australia, Australia.
Publikováno v:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2022 Sep; Vol. 66 (6), pp. 881-895. Date of Electronic Publication: 2022 Jun 14.
Autor:
de Almeida LGN; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Thode H; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Eslambolchi Y; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Chopra S; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Young D; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Gill S; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Devel L; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.)., Dufour A; Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada (L.G.N.d.A., Y.E., S.C., D.Y., A.D.); Department of Physiology and Pharmacology, University of Western Ontario, London, Canada (S.G., H.T.); and Université Paris-Saclay, CEA, INRAE, Medicaments et Technologies pour la Santé, Gif-sur-Yvette, France (L.D.) antoine.dufour@ucalgary.ca.
Publikováno v:
Pharmacological reviews [Pharmacol Rev] 2022 Jul; Vol. 74 (3), pp. 712-768.
Autor:
Gill A; School of Physics, Mathematics and Computing, The University of Western Australia, Perth, WA, Australia., Smith W; Department of Radiation Oncology, Sir Charles Gairdner Hospital (SCGH), Perth, WA, Australia., Hirst A; School of Physics, Mathematics and Computing, The University of Western Australia, Perth, WA, Australia., Sabet M; School of Physics, Mathematics and Computing, The University of Western Australia, Perth, WA, Australia.; Department of Radiation Oncology, Sir Charles Gairdner Hospital (SCGH), Perth, WA, Australia., Alkhatib Z; Department of Radiation Oncology, Sir Charles Gairdner Hospital (SCGH), Perth, WA, Australia., Gill S; School of Physics, Mathematics and Computing, The University of Western Australia, Perth, WA, Australia.; Department of Radiation Oncology, Sir Charles Gairdner Hospital (SCGH), Perth, WA, Australia., Rowshanfarzad P; School of Physics, Mathematics and Computing, The University of Western Australia, Perth, WA, Australia.
Publikováno v:
PloS one [PLoS One] 2022 May 05; Vol. 17 (5), pp. e0267741. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).
Autor:
Sloas C; Carisma Therapeutics, Philadelphia, PA, United States., Gill S; Division of Hematology-Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States., Klichinsky M; Carisma Therapeutics, Philadelphia, PA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Nov 24; Vol. 12, pp. 783305. Date of Electronic Publication: 2021 Nov 24 (Print Publication: 2021).